Table 1.
Respondent Characteristics Associated with Prevalence of Use of Potentially Inappropriate Medications
| Characteristic | Use of a Sedative‐Hypnotic | Use of Glyburide | Use of Proton Pump Inhibitor | Total | |||
|---|---|---|---|---|---|---|---|
| % (95% CI) | P‐Value for Difference | % (95% CI) | P‐Value for Difference | % (95% CI) | P‐Value for Difference | % (95% CI) | |
| Agea | |||||||
| 65–79 (n = 1,890) | 16.0 (14.4–17.7) | .002 | 3.8 (3.0–4.7) | .18 | 28.1 (26.1–30.2) | .03 | 72.7 (70.8–74.6) |
| ≥80 (n = 710) | 21.5 (18.4–24.5) | 2.7 (1.5–3.9) | 23.8 (20.6–26.9) | 27.3 (25.7–28.9) | |||
| Sex | |||||||
| Male (n = 898) | 14.1 (11.8–16.4) | .001 | 4.4 (3.1–5.8) | .08 | 19.6 (16.9–22.2) | <.001 | 33.7 (32.1–35.4) |
| Female (n = 1,767) | 19.5 (17.6–21.4) | 3.0 (2.2–3.8) | 30.8 (28.6–33.0) | 66.3 (64.4–68.1) | |||
| Language | |||||||
| English (n = 2,031) | 16.5 (14.9–18.2) | .007 | 2.4 (1.7–3.0) | <.001 | 26.4 (24.5–28.4) | .25 | 76.2 (74.3–78.1) |
| French (n = 634) | 21.2 (18.0–24.4) | 7.2 (5.1–9.2) | 28.8 (25.3–32.4) | 23.8 (22.3–25.3) | |||
| Number of medicationsa | |||||||
| 0 (n = 114) | 11.8 (5.9–17.8) | <.001 | 0.0 (0.0–0.0) | <.001 | 3.9 (0.4–7.5) | <.001 | 4.9 (4.1–5.8) |
| 1–4 (n = 1,252) | 16.4 (14.3–18.4) | 0.9 (0.4–1.4) | 29.2 (26.7–31.8) | 54.0 (52.1–56.0) | |||
| 5–9 (n = 692) | 26.9 (23.6–30.2) | 7.4 (5.4–9.4) | 34.2 (30.7–37.7) | 29.9 (28.2–31.6) | |||
| ≥10 (n = 258) | 21.8 (16.7–26.8) | 12.1 (8.1–16.2) | 39.7 (33.6–45.9) | 11.2 (9.9–12.4) | |||
| Total (N = 2,665) | 17.6 (16.2–19.1) | 3.5 (2.8–4.2) | 27.0 (25.3–28.7) | 100.0 (100.0–100.0) | |||
a
Total does not equal 2,665 because some respondents declined to answer some questions.
CI = confidence interval.